Business Context and Reporting Period
Company: The Scotts Company (SCOTTS MIRACLE-GRO CO)
Filing Type: Form 10-K (Annual Report)
Period Ended: September 30, 1999
The Scotts Company is a leading marketer and manufacturer of lawn, garden, and horticulture products. The company operates through three principal segments: North American Consumer (Lawns, Gardens, Growing Media, and Ortho), Professional (ProTurf and Horticulture), and International. Fiscal 1999 was a transformative year marked by significant strategic acquisitions, including the Ortho business from Monsanto (January 1999), Rhone-Poulenc Jardin (October 1998), and Asef Holdings (December 1998). These moves solidified Scotts' market leadership in consumer lawn care, garden care, and pesticides, particularly through the exclusive marketing rights to Monsanto's Roundup(R) herbicide.
Key Financial Metrics
| Metric | Fiscal 1999 | Fiscal 1998 |
|---|---|---|
| Sales | $1,648.3 million | $1,113.0 million |
| Gross Profit | $659.2 million | $398.0 million |
| Operating Income | $196.1 million | $94.1 million |
| Net Income | $63.2 million | $36.3 million |
| Diluted EPS | $2.08 | $1.20 |
| Operating Margin | 11.9% | 8.5% |
| EBITDA | $256.3 million | $131.9 million |
| Total Debt | $950.0 million | $372.5 million |
| Working Capital | $274.8 million | $135.3 million |
| Cash Flow from Operations | $78.2 million | $71.0 million |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 48.1% to $1.65 billion, driven primarily by the inclusion of the Ortho business ($224.3 million) and Rhone-Poulenc Jardin, alongside organic growth in the Consumer Lawns segment (up 25%).
- Profitability: Operating income more than doubled to $196.1 million. Gross margin improved to 40.0% from 35.8% due to better raw material costs and manufacturing efficiencies.
- Debt Levels: Total debt surged to $950.0 million from $372.5 million to fund the Ortho, Rhone-Poulenc, and Asef acquisitions. This included a new $330 million senior subordinated note offering and increased borrowings under credit facilities.
- Segment Performance:
- North American Consumer: Sales rose nearly 50% to $1.1 billion.
- International: Sales doubled to $391.9 million due to European acquisitions.
- Professional: Sales declined 11% to $159.4 million due to a distribution model change in the ProTurf business.
- Unusual Items: The company recorded an extraordinary loss of $5.9 million (net of tax) related to the early extinguishment of debt. Restructuring charges were minimal at $1.4 million compared to $20.4 million in 1998.
Guidance, Outlook, and Risks
Management Outlook: Management projects core business sales growth of 6% to 8% and aims for an aggregate operating margin improvement of at least 2% over the next four years. The company targets a compounded annual earnings per share growth of 15% to 20%. Fiscal 2000 capital expenditures are estimated at approximately $70 million.
Key Risks and Contingencies:
- Patent Expirations: The U.S. patent for glyphosate (Roundup's active ingredient) expires in September 2000, and the patent for Scotts Turf Builder's methylene-urea composition expires in July 2001. Expiration could lead to increased competition and sales declines.
- Customer Concentration: The top three customers (Home Depot, Wal-Mart, Kmart) accounted for approximately 38% of fiscal 1999 sales. Loss of any major customer could materially impact results.
- Environmental Liabilities: Ongoing negotiations with the Ohio EPA regarding the Marysville facility carry an estimated potential loss range of $2 million to $10 million. Other environmental matters exist in the U.K. and New Jersey.
- Legal Proceedings: Pending antitrust and breach of contract litigation with AgrEvo Environmental Health, Inc. regarding the Roundup marketing agreement and the purchase of the AgrEvo herbicide business.
- Seasonality: Approximately 74% of sales occur in the second and third fiscal quarters, creating cash flow volatility.
Investor Verification Checklist
- Verify the final purchase price adjustment for the Ortho acquisition, as working capital disputes with Monsanto were ongoing at year-end.
- Monitor sales trends for Roundup(R) and Turf Builder(R) products following the expiration of their respective U.S. patents in 2000 and 2001.
- Assess the integration progress of the Ortho and Rhone-Poulenc Jardin businesses to ensure projected cost synergies are realized.
- Review the resolution of the Ohio EPA enforcement action at the Marysville facility to confirm the final remediation costs.
- Track the impact of the distribution model change in the Professional segment on future sales volumes.